Cancer: Drugs
2026-05-17 · Department of Health and Social Care · HL205 · Official question
Question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 30 March (HL15661), what assessment they have made of the impact on equitable access to precision cancer treatments if non-genomic biomarker testing is not guaranteed for
Answer
The National Cancer Plan commitment for all cancer patients who would benefit from a genomic test to receive one to inform treatment decisions applies specifically to genomic testing. While the Plan supports the wider use of biomarker testing, including n...